| Dr Patrick Robert Huffman, PHARMD | |
|
200 Veterans Avenue, Beckley, WV 25801 | |
| (304) 255-2121 | |
| Not Available |
| Full Name | Dr Patrick Robert Huffman |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 200 Veterans Avenue, Beckley, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053636704 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 20368 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patrick Robert Huffman, PHARMD 200 Veterans Ave, Beckley, WV 25801-6444 Ph: (304) 255-2121 | Dr Patrick Robert Huffman, PHARMD 200 Veterans Avenue, Beckley, WV 25801 Ph: (304) 255-2121 |
News Archive
One of the largest studies undertaken has explored the risk of transmitting HIV infection by an HIV infected partner to his non-infected gay partner. Results reveal that HIV positive men who are on medication for HIV that makes their virus load undetectable in blood are not likely to transmit the infection to their non-infected partners.
The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial.
The U.S. Food and Drug Administration today approved the first totally implanted artificial heart for patients with advanced heart failure involving both pumping chambers of the heart under the Humanitarian Use Device (HUD) provisions of the Food, Drug and Cosmetic Act.
A team of researchers from Carnegie Mellon University is starting a project to design and implement a noninvasive neural interface that can be used as a wearable device.
Shire plc, the global specialty biopharmaceutical company, today announced the results of a study evaluating the safety and efficacy of Vyvanse (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder in adolescents aged 13 to 17 years.
› Verified 1 days ago
Mr. Robert Kirkpatrick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Beckley Plz, Beckley, WV 25801 Phone: 304-252-8522 | |
Cynthia Wills, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1881 Robert C Byrd Dr, Beckley, WV 25801 Phone: 304-256-6496 | |
Brandi Alexandra Keaton, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 221 George St, Beckley, WV 25801 Phone: 681-207-7334 | |
Gary Nathan Brown, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3159 Robert C Byrd Dr, Beckley, WV 25801 Phone: 304-255-6337 Fax: 304-255-6388 | |
Dr. Natalie Paige Cochran, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 252 Rural Acres Dr, Beckley, WV 25801 Phone: 304-252-8324 | |
Tyler Bryant Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Veterans Ave, Beckley, WV 25801 Phone: 304-255-2121 |